Product
Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma
1 clinical trial
1 indication
Indication
Rabies Vaccine Adverse ReactionClinical trial
Randomized, Blind, Phase III Clinical Trial Comparing the Immunogenicity and Safety of Freeze-dried Human Rabies Vaccine (MRC-5 Cells) With a 5-dose Program and a 4-dose (2-dose First-dose) ProgramStatus: Completed, Estimated PCD: 2021-07-21